Dihydrocodeine - Revision history

Druginfowiki Moderator at 07:54, 10 March 2026

2026-03-10T07:54:09Z

Druginfowiki Moderator at 07:46, 10 March 2026

2026-03-10T07:46:50Z

← Older revision		Revision as of 07:46, 10 March 2026
Line 26:		Line 26:
	! colspan="2" style="background-color: #343A40; color: white; padding: 10px;" \| Dosage Levels		! colspan="2" style="background-color: #343A40; color: white; padding: 10px;" \| Dosage Levels
	\|-		\|-
	\| style="background-color: #007BFF; color: white; padding: 8px;" \| 5-~~20mg~~		\| style="background-color: #007BFF; color: white; padding: 8px;" \| 5-10mg
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Threshhold		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Threshhold
	\|-		\|-
	\| style="background-color: #28A745; color: white; padding: 8px;" \| 20-~~40mg~~		\| style="background-color: #28A745; color: white; padding: 8px;" \| 10-30mg
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Light		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Light
	\|-		\|-
	\| style="background-color: #E83E8C; color: white; padding: 8px;" \|		\| style="background-color: #E83E8C; color: white; padding: 8px;" \| 30-40mg
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Common		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Common
	\|-		\|-

Druginfowiki Moderator at 07:44, 10 March 2026

2026-03-10T07:44:58Z

Druginfowiki moderator at 05:25, 9 March 2026

2026-03-09T05:25:38Z

← Older revision		Revision as of 05:25, 9 March 2026
Line 15:		Line 15:
	\| Molecule weight: 301		\| Molecule weight: 301
	\|-		\|-
	\| ~~Routes~~ of administration: ~~oral has to be~~ the ~~most good~~ way to take Dihydrocodeine. ~~About~~ the prodrug oral vs other route, please ~~go to~~ the hyperlinked document		\| Route of administration: orally dosing is the preferred way to take Dihydrocodeine. Regarding the prodrug oral vs other route, please visit the hyperlinked document
	\|-		\|-
	\| Oral bioactivity: 21% (range 12-34;rathers between person’s activity of CYP2D6). <ref>Rowell, F. J., Seymour, R. A., & Rawlins, M. D. (1983). Pharmacokinetics of intravenous and oral dihydrocodeine and its acid metabolites. European Journal of Clinical Pharmacology, 25(3), pp. 419–424.</ref> It can be more active when it takes together with grapefruit		\| Oral bioactivity: 21% (range 12-34;rathers between person’s activity of CYP2D6). <ref>Rowell, F. J., Seymour, R. A., & Rawlins, M. D. (1983). Pharmacokinetics of intravenous and oral dihydrocodeine and its acid metabolites. European Journal of Clinical Pharmacology, 25(3), pp. 419–424.</ref> It can be more active when it takes together with grapefruit

Druginfowiki moderator at 01:39, 9 March 2026

2026-03-09T01:39:40Z

← Older revision		Revision as of 01:39, 9 March 2026
Line 27:		Line 27:
	\|-		\|-
	\| style="background-color: #007BFF; color: white; padding: 8px;" \| 20-50mg		\| style="background-color: #007BFF; color: white; padding: 8px;" \| 20-50mg
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| ~~Minimal~~		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Threshhold
	\|-		\|-
	\| style="background-color: #28A745; color: white; padding: 8px;" \| 50-100mg		\| style="background-color: #28A745; color: white; padding: 8px;" \| 50-100mg

Druginfowiki Moderator: /* Legal status by each country */

2026-03-09T01:27:55Z

Legal status by each country

← Older revision		Revision as of 01:27, 9 March 2026
Line 186:		Line 186:
	In Germany, dihydrocodeine is a controlled substance under Anlage III of the BtMG. It can only be prescribed on a narcotic prescription form. There is an exception for preperations, containing up to 2,5% or 100mg dihydrocodeine per unit, which can be prescripted on a regular prescription, if not prescripted to an alcohol or drug dependent person. <ref>Gesetze im Internet. (2001). "Betäubungsmittelgesetz (BtMG) Anlage III". Retrieved from [http://www.gesetze-im-internet.de/btmg_1981/anlage_iii.html Federal Ministry of Justice and Consumer Protection].</ref>		In Germany, dihydrocodeine is a controlled substance under Anlage III of the BtMG. It can only be prescribed on a narcotic prescription form. There is an exception for preperations, containing up to 2,5% or 100mg dihydrocodeine per unit, which can be prescripted on a regular prescription, if not prescripted to an alcohol or drug dependent person. <ref>Gesetze im Internet. (2001). "Betäubungsmittelgesetz (BtMG) Anlage III". Retrieved from [http://www.gesetze-im-internet.de/btmg_1981/anlage_iii.html Federal Ministry of Justice and Consumer Protection].</ref>

	In Australia, Dihydrocodeine is a Schedule 3 medicine meaning it is available without prescription but is stored behind the counter at a pharmacy. Consultation with pharmacist is required for purchase. It is most commonly available as an oral liquid (Brand name Rikodeine) at a dose of 19mg/10mL in 100 or 200mL bottles. <ref>NPS MedicineWise. (2021). "Rikodeine Oral Liquid". Retrieved from [https://www.nps.org.au/medicine-finder/rikodeine-oral-liquid NPS MedicineWise].</ref <ref>Therapeutic Goods Administration (TGA). (n.d.). "ARTG Record: Rikodeine oral liquid". Australian Register of Therapeutic Goods. [https://search.tga.gov.au/s/search.html?collection=tga-artg&profile=record&meta_i=10587 TGA ARTG Entry].</ref>		In Australia, Dihydrocodeine is a Schedule 3 medicine meaning it is available without prescription but is stored behind the counter at a pharmacy. Consultation with pharmacist is required for purchase. It is most commonly available as an oral liquid (Brand name Rikodeine) at a dose of 19mg/10mL in 100 or 200mL bottles. <ref>NPS MedicineWise. (2021). "Rikodeine Oral Liquid". Retrieved from [https://www.nps.org.au/medicine-finder/rikodeine-oral-liquid NPS MedicineWise].</ref> <ref>Therapeutic Goods Administration (TGA). (n.d.). "ARTG Record: Rikodeine oral liquid". Australian Register of Therapeutic Goods. [https://search.tga.gov.au/s/search.html?collection=tga-artg&profile=record&meta_i=10587 TGA ARTG Entry].</ref>

	In Austria, dihydrocodeine is legal for medical use under the AMG (Arzneimittelgesetz Österreich) and illegal when sold or possessed without a prescription under the SMG (Suchtmittelgesetz Österreich). <ref>PsychonautWiki. (2024). "Dihydrocodeine". Retrieved from [https://m.psychonautwiki.org/wiki/Dihydrocodeine PsychonautWiki].</ref>		In Austria, dihydrocodeine is legal for medical use under the AMG (Arzneimittelgesetz Österreich) and illegal when sold or possessed without a prescription under the SMG (Suchtmittelgesetz Österreich). <ref>PsychonautWiki. (2024). "Dihydrocodeine". Retrieved from [https://m.psychonautwiki.org/wiki/Dihydrocodeine PsychonautWiki].</ref>

Druginfowiki Moderator: /* Legal status by each country */

2026-03-09T01:26:26Z

Legal status by each country

← Older revision		Revision as of 01:26, 9 March 2026
Line 170:		Line 170:

	Dihydrocodeine is available in Japan as tablets name SS bron which contain 2.5 mg of dihydrocodeine phosphate and caffeine, the decongestant d,l-methylephedrine HCl, and the antihistamine chlorpheniramine		Dihydrocodeine is available in Japan as tablets name SS bron which contain 2.5 mg of dihydrocodeine phosphate and caffeine, the decongestant d,l-methylephedrine HCl, and the antihistamine chlorpheniramine

			In the United Kingdom, dihydrocodeine is a Class B drug; but, it is available over-the-counter in small amounts (less than 8 mg), when combined with paracetamol (see co-dydramol). Dihydrocodeine is listed in Schedule 5 of the Misuse of Drugs Regulations 2001 whereby it is exempt from prohibition on possession provided that it is in the form of a single preparation not being designed for injection and less than 100 mg (calculated as free base) or with a total concentration less than 2.5% (calculated as free base). Illegal possession of dihydrocodeine can result in up to 5 years in prison and/or a fine.

	In United States, The Panlor series is manufactured by Pan-American Laboratories of Covington, Louisiana, and they also market several dihydrocodeine-based prescription cough syrups. Dihydrocodeine itself is a DEA Schedule II substance, although preparations containing small amounts of dihydrocodeine are classified as Schedule III or Schedule V, depending on the concentration of dihydrocodeine relative to other active constituents, such as paracetamol (acetaminophen). This scheduling is similar to the UK's. The DEA's ACSCN for dihydrocodeine free base and all salts is 9120. The 2013 annual aggregate manufacturing quota is 250 kilos.		In United States, The Panlor series is manufactured by Pan-American Laboratories of Covington, Louisiana, and they also market several dihydrocodeine-based prescription cough syrups. Dihydrocodeine itself is a DEA Schedule II substance, although preparations containing small amounts of dihydrocodeine are classified as Schedule III or Schedule V, depending on the concentration of dihydrocodeine relative to other active constituents, such as paracetamol (acetaminophen). This scheduling is similar to the UK's. The DEA's ACSCN for dihydrocodeine free base and all salts is 9120. The 2013 annual aggregate manufacturing quota is 250 kilos.
	<ref>from wikipedia, [https://en.wikipedia.org/wiki/Dihydrocodeine]</ref> <ref>PsychonautWiki. (2024). "Dihydrocodeine". Retrieved from [https://m.psychonautwiki.org/wiki/Dihydrocodeine PsychonautWiki].</ref>		<ref>from wikipedia, [https://en.wikipedia.org/wiki/Dihydrocodeine]</ref> <ref>PsychonautWiki. (2024). "Dihydrocodeine". Retrieved from [https://m.psychonautwiki.org/wiki/Dihydrocodeine PsychonautWiki].</ref>

	In Korea, ~~there~~ is Coupu tablets and syrups, and also Codewon tablets and syrups. All needs perscription, and tablets contains 5mg of DHC, syrups contains 10mg. All combined with anti-histamines and others.		In Korea, dihydrocodeine itself is in ‘마약‘ but in some conditions, <ref>국가법령정보센터. (n.d.). 마약류 관리에 관한 법률 시행규칙 제2조(한외마약). [https://www.law.go.kr/법령/마약류관리에관한법률시행규칙/제2조 마약류 관리에 관한 법률 시행규칙 제2조].</ref>it is in ‘한외마약’, which is way more free to perscribe, and it is the main cough medicine in Korea. There is Coupu tablets and syrups, and also Codewon tablets and syrups. All needs perscription, and tablets contains 5mg of DHC, syrups contains 10mg. All combined with anti-histamines and others.

			In Switzerland, Dihydrocodeine is a controlled substance specifically named under Verzeichnis A. Medicinal use is permitted. Some preparations containing dihydrocodeine are included in Verzechnis C, while certain ones are excluded.

			In Russia, Dihydrocodeine is a Schedule II controlled substance. <ref>Consultant.ru. (2019). "Russian Federation Law on Narcotic Drugs and Psychotropic Substances". Retrieved from [https://www.consultant.ru/cons/cgi/online.cgi?req=doc&base=LAW&n=331879 Russian Legal Database].</ref>

			In Hong Kong, dihydrocodeine is regulated under Schedule 1 of Hong Kong's Chapter 134 Dangerous Drugs Ordinance. It can only be used legally by health professionals and for university research purposes. A pharmacist can dispense Dihydrocodeine when furnished with a doctors prescription. Anyone who supplies the substance without a prescription can be fined $10000 (HKD). The penalty for trafficking or manufacturing the substance is a $5,000,000 (HKD) fine and life imprisonment. Possession of the substance for consumption, without a licence from the Department of Health, is illegal and carries a $1,000,000 (HKD) fine and/or 7 years imprisonment.

			In Germany, dihydrocodeine is a controlled substance under Anlage III of the BtMG. It can only be prescribed on a narcotic prescription form. There is an exception for preperations, containing up to 2,5% or 100mg dihydrocodeine per unit, which can be prescripted on a regular prescription, if not prescripted to an alcohol or drug dependent person. <ref>Gesetze im Internet. (2001). "Betäubungsmittelgesetz (BtMG) Anlage III". Retrieved from [http://www.gesetze-im-internet.de/btmg_1981/anlage_iii.html Federal Ministry of Justice and Consumer Protection].</ref>

			In Australia, Dihydrocodeine is a Schedule 3 medicine meaning it is available without prescription but is stored behind the counter at a pharmacy. Consultation with pharmacist is required for purchase. It is most commonly available as an oral liquid (Brand name Rikodeine) at a dose of 19mg/10mL in 100 or 200mL bottles. <ref>NPS MedicineWise. (2021). "Rikodeine Oral Liquid". Retrieved from [https://www.nps.org.au/medicine-finder/rikodeine-oral-liquid NPS MedicineWise].</ref <ref>Therapeutic Goods Administration (TGA). (n.d.). "ARTG Record: Rikodeine oral liquid". Australian Register of Therapeutic Goods. [https://search.tga.gov.au/s/search.html?collection=tga-artg&profile=record&meta_i=10587 TGA ARTG Entry].</ref>

			In Austria, dihydrocodeine is legal for medical use under the AMG (Arzneimittelgesetz Österreich) and illegal when sold or possessed without a prescription under the SMG (Suchtmittelgesetz Österreich). <ref>PsychonautWiki. (2024). "Dihydrocodeine". Retrieved from [https://m.psychonautwiki.org/wiki/Dihydrocodeine PsychonautWiki].</ref>

	== References ==		== References ==

	<references />		<references />

Druginfowiki Moderator: /* Legal status by each country */

2026-03-09T01:13:20Z

Legal status by each country

← Older revision		Revision as of 01:13, 9 March 2026
Line 172:		Line 172:

	In United States, The Panlor series is manufactured by Pan-American Laboratories of Covington, Louisiana, and they also market several dihydrocodeine-based prescription cough syrups. Dihydrocodeine itself is a DEA Schedule II substance, although preparations containing small amounts of dihydrocodeine are classified as Schedule III or Schedule V, depending on the concentration of dihydrocodeine relative to other active constituents, such as paracetamol (acetaminophen). This scheduling is similar to the UK's. The DEA's ACSCN for dihydrocodeine free base and all salts is 9120. The 2013 annual aggregate manufacturing quota is 250 kilos.		In United States, The Panlor series is manufactured by Pan-American Laboratories of Covington, Louisiana, and they also market several dihydrocodeine-based prescription cough syrups. Dihydrocodeine itself is a DEA Schedule II substance, although preparations containing small amounts of dihydrocodeine are classified as Schedule III or Schedule V, depending on the concentration of dihydrocodeine relative to other active constituents, such as paracetamol (acetaminophen). This scheduling is similar to the UK's. The DEA's ACSCN for dihydrocodeine free base and all salts is 9120. The 2013 annual aggregate manufacturing quota is 250 kilos.
	<ref>from wikipedia, [https://en.wikipedia.org/wiki/Dihydrocodeine]</ref>		<ref>from wikipedia, [https://en.wikipedia.org/wiki/Dihydrocodeine]</ref> <ref>PsychonautWiki. (2024). "Dihydrocodeine". Retrieved from [https://m.psychonautwiki.org/wiki/Dihydrocodeine PsychonautWiki].</ref>

	In Korea, there is Coupu tablets and syrups, and also Codewon tablets and syrups. All needs perscription, and tablets contains 5mg of DHC, syrups contains 10mg. All combined with anti-histamines and others.		In Korea, there is Coupu tablets and syrups, and also Codewon tablets and syrups. All needs perscription, and tablets contains 5mg of DHC, syrups contains 10mg. All combined with anti-histamines and others.

Druginfowiki Moderator: /* Legal status by each country */

2026-03-09T01:12:49Z

Legal status by each country

← Older revision		Revision as of 01:12, 9 March 2026
Line 171:		Line 171:
	Dihydrocodeine is available in Japan as tablets name SS bron which contain 2.5 mg of dihydrocodeine phosphate and caffeine, the decongestant d,l-methylephedrine HCl, and the antihistamine chlorpheniramine		Dihydrocodeine is available in Japan as tablets name SS bron which contain 2.5 mg of dihydrocodeine phosphate and caffeine, the decongestant d,l-methylephedrine HCl, and the antihistamine chlorpheniramine

	In United States, The Panlor series is manufactured by Pan-American Laboratories of Covington, Louisiana, and they also market several dihydrocodeine-based prescription cough syrups.		In United States, The Panlor series is manufactured by Pan-American Laboratories of Covington, Louisiana, and they also market several dihydrocodeine-based prescription cough syrups. Dihydrocodeine itself is a DEA Schedule II substance, although preparations containing small amounts of dihydrocodeine are classified as Schedule III or Schedule V, depending on the concentration of dihydrocodeine relative to other active constituents, such as paracetamol (acetaminophen). This scheduling is similar to the UK's. The DEA's ACSCN for dihydrocodeine free base and all salts is 9120. The 2013 annual aggregate manufacturing quota is 250 kilos.
	<ref>~~photo of the chemical structure is~~ from wikipedia, [https://en.wikipedia.org/wiki/Dihydrocodeine]</ref>		<ref>from wikipedia, [https://en.wikipedia.org/wiki/Dihydrocodeine]</ref>

	In Korea, there is Coupu tablets and syrups, and also Codewon tablets and syrups. All needs perscription, and tablets contains 5mg of DHC, syrups contains 10mg. All combined with anti-histamines and others.		In Korea, there is Coupu tablets and syrups, and also Codewon tablets and syrups. All needs perscription, and tablets contains 5mg of DHC, syrups contains 10mg. All combined with anti-histamines and others.

Druginfowiki Moderator at 01:09, 9 March 2026

2026-03-09T01:09:46Z

← Older revision		Revision as of 01:09, 9 March 2026
Line 172:		Line 172:

	In United States, The Panlor series is manufactured by Pan-American Laboratories of Covington, Louisiana, and they also market several dihydrocodeine-based prescription cough syrups.		In United States, The Panlor series is manufactured by Pan-American Laboratories of Covington, Louisiana, and they also market several dihydrocodeine-based prescription cough syrups.
			<ref>photo of the chemical structure is from wikipedia, [https://en.wikipedia.org/wiki/Dihydrocodeine]</ref>

	In Korea, there is Coupu tablets and syrups, and also Codewon tablets and syrups. All needs perscription, and tablets contains 5mg of DHC, syrups contains 10mg. All combined with anti-histamines and others.		In Korea, there is Coupu tablets and syrups, and also Codewon tablets and syrups. All needs perscription, and tablets contains 5mg of DHC, syrups contains 10mg. All combined with anti-histamines and others.

← Older revision		Revision as of 07:46, 10 March 2026
Line 26:		Line 26:
	! colspan="2" style="background-color: #343A40; color: white; padding: 10px;" \| Dosage Levels		! colspan="2" style="background-color: #343A40; color: white; padding: 10px;" \| Dosage Levels
	\|-		\|-
	\| style="background-color: #007BFF; color: white; padding: 8px;" \| 5-~~20mg~~		\| style="background-color: #007BFF; color: white; padding: 8px;" \| 5-10mg
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Threshhold		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Threshhold
	\|-		\|-
	\| style="background-color: #28A745; color: white; padding: 8px;" \| 20-~~40mg~~		\| style="background-color: #28A745; color: white; padding: 8px;" \| 10-30mg
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Light		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Light
	\|-		\|-
	\| style="background-color: #E83E8C; color: white; padding: 8px;" \|		\| style="background-color: #E83E8C; color: white; padding: 8px;" \| 30-40mg
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Common		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Common
	\|-		\|-

← Older revision		Revision as of 07:54, 10 March 2026
Line 26:		Line 26:
	! colspan="2" style="background-color: #343A40; color: white; padding: 10px;" \| Dosage Levels		! colspan="2" style="background-color: #343A40; color: white; padding: 10px;" \| Dosage Levels
	\|-		\|-
	\| style="background-color: #007BFF; color: white; padding: 8px;" \| 5-~~10mg~~		\| style="background-color: #007BFF; color: white; padding: 8px;" \| 20-50mg
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Threshhold		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Threshhold
	\|-		\|-
	\| style="background-color: #28A745; color: white; padding: 8px;" \| 10-~~30mg~~		\| style="background-color: #28A745; color: white; padding: 8px;" \| 50-100mg
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Light		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Light
	\|-		\|-
	\| style="background-color: #E83E8C; color: white; padding: 8px;" \| 30-~~40mg~~		\| style="background-color: #E83E8C; color: white; padding: 8px;" \| 100-150mg
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Common		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Common
	\|-		\|-
	\| style="background-color: #FD7E14; color: white; padding: 8px;" \| 40-~~60mg~~		\| style="background-color: #FD7E14; color: white; padding: 8px;" \| 150-200mg
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Strong		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Strong
	\|-		\|-
	\| style="background-color: #DC3545; color: white; padding: 8px;" \| ~~60mg~~+		\| style="background-color: #DC3545; color: white; padding: 8px;" \| 200-400mg+
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Heavy		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Heavy
	\|-		\|-
Line 44:		Line 44:
	\|-		\|-
	\| style="background-color: #6C757D; color: white; padding: 8px;" \| Onset		\| style="background-color: #6C757D; color: white; padding: 8px;" \| Onset
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| 30-40 minutes		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| 45-55 minutes
	\|-		\|-
	\| style="background-color: #6C757D; color: white; padding: 8px;" \| Comeup		\| style="background-color: #6C757D; color: white; padding: 8px;" \| Comeup
Line 50:		Line 50:
	\|-		\|-
	\| style="background-color: #6C757D; color: white; padding: 8px;" \| Peak		\| style="background-color: #6C757D; color: white; padding: 8px;" \| Peak
	\| style="background-color: #F8F9FA; black; padding: 8px;" \| 1-1.5 hours		\| style="background-color: #F8F9FA; black; padding: 8px;" \| 2-2.5 hours
	\|-		\|-
	\| style="background-color: #6C757D; color: white; padding: 8px;" \| Offset		\| style="background-color: #6C757D; color: white; padding: 8px;" \| Offset
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| ~~1.5~~-2 hours		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| 3-4 hours
	\|-		\|-
	\| style="background-color: #343A40; color: white; padding: 10px;" \| Total Duration		\| style="background-color: #343A40; color: white; padding: 10px;" \| Total Duration
	\| style="background-color: #E9ECEF; color: black; padding: 10px;" \| 4-5 hours		\| style="background-color: #E9ECEF; color: black; padding: 10px;" \| 7-8 hours
			\|-
			\| style="background-color: #343A40; color: white; padding: 10px;" \| Half-life
			\| style="background-color: #E9ECEF; color: black; padding: 10px;" \| 3.3-4.5 hours
	\|}		\|}


	<ref>Rowell, F. J., Seymour, R. A., & Rawlins, M. D. (1983). Pharmacokinetics of intravenous and oral dihydrocodeine and its acid metabolites. European Journal of Clinical Pharmacology, 25(3), 419–424.</ref>		<ref>Rowell, F. J., Seymour, R. A., & Rawlins, M. D. (1983). Pharmacokinetics of intravenous and oral dihydrocodeine and its acid metabolites. European Journal of Clinical Pharmacology, 25(3), 419–424.</ref>

← Older revision		Revision as of 07:44, 10 March 2026
Line 26:		Line 26:
	! colspan="2" style="background-color: #343A40; color: white; padding: 10px;" \| Dosage Levels		! colspan="2" style="background-color: #343A40; color: white; padding: 10px;" \| Dosage Levels
	\|-		\|-
	\| style="background-color: #007BFF; color: white; padding: 8px;" \| 20-~~50mg~~		\| style="background-color: #007BFF; color: white; padding: 8px;" \| 5-20mg
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Threshhold		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Threshhold
	\|-		\|-
	\| style="background-color: #28A745; color: white; padding: 8px;" \| 50-~~100mg~~		\| style="background-color: #28A745; color: white; padding: 8px;" \| 20-40mg
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Light		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Light
	\|-		\|-
	\| style="background-color: #E83E8C; color: white; padding: 8px;" \| ~~100-150mg~~		\| style="background-color: #E83E8C; color: white; padding: 8px;" \|
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Common		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Common
	\|-		\|-
	\| style="background-color: #FD7E14; color: white; padding: 8px;" \| ~~150~~-~~200mg~~		\| style="background-color: #FD7E14; color: white; padding: 8px;" \| 40-60mg
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Strong		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Strong
	\|-		\|-
	\| style="background-color: #DC3545; color: white; padding: 8px;" \| ~~200-400mg~~+		\| style="background-color: #DC3545; color: white; padding: 8px;" \| 60mg+
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Heavy		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| Heavy
	\|-		\|-
Line 44:		Line 44:
	\|-		\|-
	\| style="background-color: #6C757D; color: white; padding: 8px;" \| Onset		\| style="background-color: #6C757D; color: white; padding: 8px;" \| Onset
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| 45-55 minutes		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| 30-40 minutes
	\|-		\|-
	\| style="background-color: #6C757D; color: white; padding: 8px;" \| Comeup		\| style="background-color: #6C757D; color: white; padding: 8px;" \| Comeup
Line 50:		Line 50:
	\|-		\|-
	\| style="background-color: #6C757D; color: white; padding: 8px;" \| Peak		\| style="background-color: #6C757D; color: white; padding: 8px;" \| Peak
	\| style="background-color: #F8F9FA; black; padding: 8px;" \| 2-2.5 hours		\| style="background-color: #F8F9FA; black; padding: 8px;" \| 1-1.5 hours
	\|-		\|-
	\| style="background-color: #6C757D; color: white; padding: 8px;" \| Offset		\| style="background-color: #6C757D; color: white; padding: 8px;" \| Offset
	\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| 3-4 hours		\| style="background-color: #F8F9FA; color: black; padding: 8px;" \| 1.5-2 hours
	\|-		\|-
	\| style="background-color: #343A40; color: white; padding: 10px;" \| Total Duration		\| style="background-color: #343A40; color: white; padding: 10px;" \| Total Duration
	\| style="background-color: #E9ECEF; color: black; padding: 10px;" \| ~~7-8 hours~~		\| style="background-color: #E9ECEF; color: black; padding: 10px;" \| 4-5 hours
	\|-
	~~\| style="background~~-~~color: #343A40; color: white; padding: 10px;" \| Half-life~~
	~~\| style="background-color: #E9ECEF; color: black; padding: 10px;" \| 3.3-4.~~5 hours
	\|}		\|}